| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 68,123 | 66,717 | 66,704 | 76,559 | | Cost of Revenue | 6,591 | 6,498 | 8,019 | 8,931 | | | Gross Profit | 61,532 | 60,219 | 58,685 | 67,628 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,172 | 5,133 | 4,743 | 2,862 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 11,920 | 11,834 | 12,629 | 11,645 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (110,509) | 43,252 | 41,313 | 53,121 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (552) | | Earnings Before Interest And Taxes | (230,540) | 43,033 | 41,532 | 53,667 | | Interest Expense | (34,919) | 17,482 | 17,437 | 18,282 | | Income Before Tax | (195,621) | 25,551 | 24,095 | 35,385 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| 879 | | | | Net Income From Continuing Ops | (75,361) | 25,995 | 24,095 | 35,385 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (56,347) | 25,995 | 24,095 | 35,386 | | Preferred Stock And Other Adjustments | (10,495) | (13,394) | 1,234 | (7,552) | | | Net Income Applicable To Common Shares | ($66,842) | $12,601 | $25,329 | $27,834 |
|
0.02% Nasdaq 
Income Statement
